PKM and breast cancer: Thereby expressing and secreting miR-122, breast cancer cells control the glucose consumption by non-malignant cells, which will uptake miR-122 and reduce PKM2 expression, and consequently glycolysis, in such way increasing glucose bioavailability to be used by cancer cells (51).